SGN timeline
Every SGN batch the index holds, newest manufacture date first, with the supplier's declared purity beside the median of the index's independent observations of the same lot.
| Lot | Compound | Manufactured | Quarter | Tests | Independent median | Spread (pp) | COA purity | Divergence (pp) | |
|---|---|---|---|---|---|---|---|---|---|
| SGN-2605-X9661 | ARA-290 | 24 May 2026 | 2026-Q2 | 2 | 98.27 | 0.62 | 98.55 | +0.28 | |
| SGN-2603-X9044 | GHK-Cu | 26 Mar 2026 | 2026-Q2 | 1 | 97.53 | n<2 | 98.27 | +0.74 | |
| SGN-2602-X9969 | SLU-PP-332 | 28 Feb 2026 | 2026-Q2 | 12 | 98.29 | 1.17 | 98.70 | +0.41 | |
| SGN-2602-Y9898 | Afamelanotide | 25 Feb 2026 | 2026-Q3 | 2 | 99.06 | 0.27 | 99.00 | -0.06 | |
| SGN-2602-L1809 | Melanotan II | 25 Feb 2026 | 2026-Q2 | 12 | 98.77 | 1.27 | 99.05 | +0.28 | |
| SGN-2602-K1833 | Melanotan II | 25 Feb 2026 | 2026-Q2 | 2 | 97.39 | 1.07 | 97.48 | +0.09 | |
| SGN-2601-A1088 | Kisspeptin-10 | 18 Jan 2026 | 2026-Q2 | 1 | 98.39 | n<2 | 99.00 | +0.61 | |
| SGN-2512-H1950 | BPC-157 | 23 Dec 2025 | 2026-Q2 | 14 | 98.54 | 0.88 | 98.67 | +0.13 | SHARED BULK |
| SGN-2512-Y1213 | Thymosin α1 | 16 Dec 2025 | 2026-Q2 | 1 | 99.13 | n<2 | 99.53 | +0.40 | |
| SGN-2511-G1523 | Epitalon | 07 Nov 2025 | 2025-Q4 | 1 | 99.56 | n<2 | 99.77 | +0.21 | |
| SGN-2510-R8898 | Afamelanotide | 23 Oct 2025 | 2025-Q4 | 4 | 98.11 | 1.52 | 98.86 | +0.75 | |
| SGN-2510-P9566 | GHRP-6 | 08 Oct 2025 | 2026-Q1 | 5 | 98.68 | 0.77 | 99.40 | +0.72 | |
| SGN-2508-Y1438 | Selank | 26 Aug 2025 | 2026-Q1 | 3 | 98.41 | 0.88 | 98.78 | +0.37 | |
| SGN-2508-K1228 | N-Acetyl Semax Amide | 25 Aug 2025 | 2026-Q1 | 6 | 99.52 | 1.03 | 99.67 | +0.15 | |
| SGN-2508-U1379 | Melanotan II | 23 Aug 2025 | 2025-Q3 | 2 | 98.33 | 0.06 | 99.00 | +0.67 | |
| SGN-2507-F9952 | BPC-157 | 20 Jul 2025 | 2025-Q3 | 3 | 98.60 | 0.93 | 98.91 | +0.31 | |
| SGN-2507-W1162 | Tirzepatide | 18 Jul 2025 | 2025-Q3 | 1 | 97.20 | n<2 | 98.00 | +0.80 | |
| SGN-2507-U1475 | SS-31 (Elamipretide) | 11 Jul 2025 | 2025-Q4 | 4 | 97.07 | 0.59 | 97.37 | +0.30 | |
| SGN-2506-M9512 | TB-500 | 15 Jun 2025 | 2025-Q3 | 1 | 99.17 | n<2 | 99.55 | +0.38 | |
| SGN-2506-J8941 | Tirzepatide | 15 Jun 2025 | 2025-Q3 | 8 | 97.12 | 1.55 | 97.76 | +0.64 | SHARED BULK |
| SGN-2505-Y9398 | N-Acetyl Semax Amide | 25 May 2025 | 2025-Q3 | 5 | 99.26 | 0.66 | 99.76 | +0.50 | |
| SGN-2505-A9617 | PT-141 (Bremelanotide) | 18 May 2025 | 2025-Q3 | 11 | 98.20 | 0.57 | 99.00 | +0.80 | |
| SGN-2505-G9671 | Tirzepatide | 05 May 2025 | 2025-Q4 | 4 | 98.72 | 0.95 | 99.07 | +0.35 | |
| SGN-2504-A9926 | Triptorelin | 30 Apr 2025 | 2025-Q2 | 6 | 98.40 | 0.72 | 98.55 | +0.15 | |
| SGN-2504-P9721 | Thymosin α1 | 17 Apr 2025 | 2025-Q3 | 1 | 99.33 | n<2 | 99.45 | +0.12 | |
| SGN-2504-X1136 | GHRP-6 | 10 Apr 2025 | 2025-Q3 | 7 | 98.62 | 1.09 | 98.79 | +0.17 | |
| SGN-2503-S9853 | MGF | 08 Mar 2025 | 2025-Q2 | 3 | 99.06 | 0.73 | 99.52 | +0.46 | |
| SGN-2503-P1233 | Tirzepatide | 05 Mar 2025 | 2025-Q2 | 5 | 97.85 | 0.82 | 97.70 | -0.15 | |
| SGN-2502-Y8932 | Sermorelin | 14 Feb 2025 | 2025-Q3 | 5 | 98.75 | 1.00 | 99.32 | +0.57 | |
| SGN-2502-F9601 | Semaglutide | 13 Feb 2025 | 2025-Q3 | 5 | 99.13 | 1.52 | 99.42 | +0.29 | |
| SGN-2502-J9961 | Semaglutide | 12 Feb 2025 | 2025-Q2 | 3 | 98.18 | 0.89 | 98.66 | +0.48 | |
| SGN-2502-W8745 | Ipamorelin | 04 Feb 2025 | 2025-Q2 | 2 | 99.11 | 0.48 | 98.80 | -0.31 | |
| SGN-2412-Y9700 | PT-141 (Bremelanotide) | 28 Dec 2024 | 2025-Q1 | 8 | 98.33 | 1.34 | 98.50 | +0.17 | SHARED BULK |
| SGN-2412-L9802 | CJC-1295 (no DAC) | 15 Dec 2024 | 2025-Q2 | 1 | 99.65 | n<2 | 100.00 | +0.35 | |
| SGN-2411-N9088 | GHRP-6 | 17 Nov 2024 | 2025-Q1 | 3 | 98.41 | 0.47 | 99.24 | +0.83 | |
| SGN-2411-N9604 | Tirzepatide | 14 Nov 2024 | 2024-Q4 | 1 | 98.80 | n<2 | 99.04 | +0.24 | |
| SGN-2410-P9717 | L-Glutathione (reduced) | 19 Oct 2024 | 2024-Q4 | 1 | 98.91 | n<2 | 99.65 | +0.74 | |
| SGN-2410-D9857 | Semaglutide | 16 Oct 2024 | 2025-Q1 | 15 | 97.81 | 1.69 | 98.52 | +0.71 | |
| SGN-2409-F8648 | Semaglutide | 30 Sep 2024 | 2024-Q4 | 9 | 98.35 | 1.93 | 98.94 | +0.59 | |
| SGN-2409-E9789 | TB-500 | 27 Sep 2024 | 2024-Q4 | 1 | 98.86 | n<2 | 99.90 | +1.04 | |
| SGN-2409-H9399 | Selank | 24 Sep 2024 | 2025-Q1 | 2 | 97.90 | 0.79 | 98.57 | +0.67 | |
| SGN-2409-D9887 | IGF-1 LR3 | 06 Sep 2024 | 2025-Q1 | 4 | 97.64 | 0.82 | 97.87 | +0.23 | |
| SGN-2408-S9172 | Tirzepatide | 22 Aug 2024 | 2024-Q4 | 7 | 97.78 | 0.80 | 98.62 | +0.84 | |
| SGN-2408-X9675 | Liraglutide | 10 Aug 2024 | 2024-Q4 | 2 | 98.45 | 0.32 | 98.86 | +0.41 | |
| SGN-2408-K1629 | CJC-1295 with DAC | 08 Aug 2024 | 2025-Q1 | 8 | 98.43 | 0.73 | 98.99 | +0.56 | |
| SGN-2407-R9967 | N-Acetyl Semax Amide | 12 Jul 2024 | 2024-Q3 | 9 | 98.51 | 1.71 | 99.05 | +0.54 | |
| SGN-2404-J1177 | CJC-1295 (no DAC) | 05 Apr 2024 | 2024-Q3 | 2 | 98.12 | 0.28 | 98.97 | +0.85 | |
| SGN-2401-K1375 | Tirzepatide | 31 Jan 2024 | 2024-Q2 | 10 | 98.31 | 1.84 | 98.47 | +0.16 | |
| SGN-2401-B9048 | GHRP-6 | 07 Jan 2024 | 2024-Q1 | 5 | 99.17 | 1.19 | 99.82 | +0.65 |